Associated Papers
An update on the monogenic causes of Parkinson's disease: Impact on patient stratification and personalised medicine.
Asmi S et al.
Ageing Research Reviews, 2026
Exploring the triad: VPS35, neurogenesis, and neurodegenerative diseases.
Qiu Z et al.
Journal of Neurochemistry, 2024
VPS35 and retromer dysfunction in Parkinson's disease.
Rowlands J et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 2024
Genetic Evidence for Endolysosomal Dysfunction in Parkinson's Disease: A Critical Overview.
Yahya V et al.
International Journal of Molecular Sciences, 2023
VPS35, the core component of the retromer complex, and Parkinson's disease.
Luo AD et al.
Ibrain, 2021
Rare VPS35 A320V Variant in Taiwanese Parkinson's Disease Indicates Disrupted CI-MPR Sorting and Impaired Mitochondrial Morphology.
Wu YR et al.
Brain Sciences, 2020
Contributions of VPS35 Mutations to Parkinson's Disease.
Rahman AA et al.
Neuroscience, 2019
The functional roles of retromer in Parkinson's disease.
Cui Y et al.
Febs Letters, 2018
VPS35, the Retromer Complex and Parkinson's Disease.
Williams ET et al.
Journal of Parkinson's Disease, 2017
Analysis of the genetic variability in Parkinson's disease from Southern Spain.
Bandrés-Ciga S et al.
Neurobiology of Aging, 2016
Select a paper to view details